Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 4Suspended 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Colorectal Neoplasms 7Breast Neoplasms 7Neoplasms 6Glioblastoma 6Neoplasm Metastasis 5Prostatic Neoplasms 4Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Multiple Myeloma 3Leukemia, Myeloid, Acute 3Glioma 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Solid Tumors 2Solid Tumor 2Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Osteosarcoma 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, T-Cell 2Lung Neoplasms 2Immunoblastic Lymphadenopathy 2Carcinoma, Renal Cell 2Carcinoma 2Brain Neoplasms 2Biliary Tract Neoplasms 2

Interventions

iadademstat 1decitabine and cedazuridine drug combination 1Specimen Handling 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Thrombocythemia, Essential × 30 days × Clear all
NCT06661915 2026-05-29

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

National Cancer Institute (NCI)

Phase 2 Suspended
62 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡